These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20360256)

  • 1. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
    Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
    Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.
    Lal H; Zhou J; Ahmad F; Zaka R; Vagnozzi RJ; Decaul M; Woodgett J; Gao E; Force T
    Circulation; 2012 Jan; 125(1):65-75. PubMed ID: 22086876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
    Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
    Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
    Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
    J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
    Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
    J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
    Cho J; Zhai P; Maejima Y; Sadoshima J
    Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte-GSK-3β deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms.
    Yusuf AM; Qaisar R; Al-Tamimi AO; Jayakumar MN; Woodgett JR; Koch WJ; Ahmad F
    J Cell Physiol; 2022 Mar; 237(3):1804-1817. PubMed ID: 34812500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
    Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
    Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DYRK2 negatively regulates cardiomyocyte growth by mediating repressor function of GSK-3β on eIF2Bε.
    Weiss CS; Ochs MM; Hagenmueller M; Streit MR; Malekar P; Riffel JH; Buss SJ; Weiss KH; Sadoshima J; Katus HA; Hardt SE
    PLoS One; 2013; 8(9):e70848. PubMed ID: 24023715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.
    Fujita A; Takahashi-Yanaga F; Morimoto S; Yoshihara T; Arioka M; Igawa K; Tomooka K; Hoka S; Sasaguri T
    Hypertens Res; 2017 Feb; 40(2):130-139. PubMed ID: 27628899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity.
    Gupte M; Umbarkar P; Singh AP; Zhang Q; Tousif S; Lal H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.
    Webb IG; Sicard P; Clark JE; Redwood S; Marber MS
    J Mol Cell Cardiol; 2010 Nov; 49(5):897-900. PubMed ID: 20696171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.
    Zhou J; Ahmad F; Parikh S; Hoffman NE; Rajan S; Verma VK; Song J; Yuan A; Shanmughapriya S; Guo Y; Gao E; Koch W; Woodgett JR; Madesh M; Kishore R; Lal H; Force T
    Circ Res; 2016 Apr; 118(8):1208-22. PubMed ID: 26976650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
    Gupte M; Tumuluru S; Sui JY; Singh AP; Umbarkar P; Parikh SS; Ahmad F; Zhang Q; Force T; Lal H
    Int J Cardiol; 2018 May; 259():145-152. PubMed ID: 29398139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure.
    Tariq U; Uppulapu SK; Banerjee SK
    Curr Drug Targets; 2021; 22(13):1568-1576. PubMed ID: 33655828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.